PERSISTENCE OF PH+/CD34+ CELLS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN PROLONGED COMPLETE CYTOGENETIC REMISSION FOLLOWING IMATINIB MESYLATE TREATMENT
Journal of the Siena Academy of Sciences · 2009
DOI: 10.4081/329 ↗At a glance
Journal article in Journal of the Siena Academy of Sciences, 2009. Written by M. Defina and 7 co-authors.
Abstract (original language)
Chronic myelogenous leukemia (CML) is characterized by a clonal expansion of a hematopoietic stem cell possessing a reciprocal translocation between chromosomes 9 and 22, the Philadelphia chromosome, as identified cytogenetically or molecularly (RT-PCR). CML accounts for 15% of adult leukemias. The disease progresses from a chronic phase through an accelerated phase to a blast phase. In the past, the National Comprehensive Cancer Network had suggested that there were three primary treatments available for CML which included: allogeneic bone marrow transplantation (BMT), IFN-α with or without cytarabine, and imatinib mesylate (Glivec®). It has been shown that Glivec is superior to the combination of interferon plus cytarabine. Although BMT can be a curative treatment for CML it is not usually used as a front-line therapy, due to limited donor availability and high toxicity of the procedure. Five-year survival rates following HLA-matched transplants are approximately 75% for patients in chronic phase.
Cite
APA
Defina, M., Bocchia, M., Ippoliti, I., Gozzetti, A., Calabrese, S., Crupi, R., Chitarrelli, I., & Lauria, F. (2009). PERSISTENCE OF PH+/CD34+ CELLS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN PROLONGED COMPLETE CYTOGENETIC REMISSION FOLLOWING IMATINIB MESYLATE TREATMENT. Journal of the Siena Academy of Sciences. https://doi.org/10.4081/329
Vancouver
Defina M, Bocchia M, Ippoliti I, Gozzetti A, Calabrese S, Crupi R, et al. PERSISTENCE OF PH+/CD34+ CELLS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN PROLONGED COMPLETE CYTOGENETIC REMISSION FOLLOWING IMATINIB MESYLATE TREATMENT. Journal of the Siena Academy of Sciences. 2009. doi:10.4081/329
BibTeX
@article{Defina2009,
author = {Defina, M. and Bocchia, M. and Ippoliti, I. and Gozzetti, A. and Calabrese, S. and Crupi, R. and Chitarrelli, I. and Lauria, F.},
title = {PERSISTENCE OF PH+/CD34+ CELLS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN PROLONGED COMPLETE CYTOGENETIC REMISSION FOLLOWING IMATINIB MESYLATE TREATMENT},
journal = {Journal of the Siena Academy of Sciences},
year = {2009},
doi = {10.4081/329}
}
EUVIMED